These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 35198441)
1. Artesunate Inhibits the Growth Behavior of Docetaxel-Resistant Prostate Cancer Cells. Vakhrusheva O; Erb HHH; Bräunig V; Markowitsch SD; Schupp P; Baer PC; Slade KS; Thomas A; Tsaur I; Puhr M; Culig Z; Cinatl J; Michaelis M; Efferth T; Haferkamp A; Juengel E Front Oncol; 2022; 12():789284. PubMed ID: 35198441 [TBL] [Abstract][Full Text] [Related]
2. Shikonin Reduces Growth of Docetaxel-Resistant Prostate Cancer Cells Mainly through Necroptosis. Markowitsch SD; Juetter KM; Schupp P; Hauschulte K; Vakhrusheva O; Slade KS; Thomas A; Tsaur I; Cinatl J; Michaelis M; Efferth T; Haferkamp A; Juengel E Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33672520 [TBL] [Abstract][Full Text] [Related]
3. Artesunate Inhibits Growth of Sunitinib-Resistant Renal Cell Carcinoma Cells through Cell Cycle Arrest and Induction of Ferroptosis. Markowitsch SD; Schupp P; Lauckner J; Vakhrusheva O; Slade KS; Mager R; Efferth T; Haferkamp A; Juengel E Cancers (Basel); 2020 Oct; 12(11):. PubMed ID: 33121039 [TBL] [Abstract][Full Text] [Related]
4. Artesunate Impairs Growth in Cisplatin-Resistant Bladder Cancer Cells by Cell Cycle Arrest, Apoptosis and Autophagy Induction. Zhao F; Vakhrusheva O; Markowitsch SD; Slade KS; Tsaur I; Cinatl J; Michaelis M; Efferth T; Haferkamp A; Juengel E Cells; 2020 Dec; 9(12):. PubMed ID: 33316936 [TBL] [Abstract][Full Text] [Related]
5. Amygdalin Exerts Antitumor Activity in Taxane-Resistant Prostate Cancer Cells. Tsaur I; Thomas A; Monecke M; Zugelder M; Rutz J; Grein T; Maxeiner S; Xie H; Chun FK; Rothweiler F; Cinatl J; Michaelis M; Haferkamp A; Blaheta RA Cancers (Basel); 2022 Jun; 14(13):. PubMed ID: 35804883 [TBL] [Abstract][Full Text] [Related]
6. Interferon inducible antiviral MxA is inversely associated with prostate cancer and regulates cell cycle, invasion and Docetaxel induced apoptosis. Brown SG; Knowell AE; Hunt A; Patel D; Bhosle S; Chaudhary J Prostate; 2015 Feb; 75(3):266-79. PubMed ID: 25327819 [TBL] [Abstract][Full Text] [Related]
7. Acetyl-11-keto-β-boswellic acid suppresses docetaxel-resistant prostate cancer cells in vitro and in vivo by blocking Akt and Stat3 signaling, thus suppressing chemoresistant stem cell-like properties. Liu YQ; Wang SK; Xu QQ; Yuan HQ; Guo YX; Wang Q; Kong F; Lin ZM; Sun DQ; Wang RM; Lou HX Acta Pharmacol Sin; 2019 May; 40(5):689-698. PubMed ID: 30171201 [TBL] [Abstract][Full Text] [Related]
8. Identification of endonuclease domain-containing 1 as a novel tumor suppressor in prostate cancer. Qiu J; Peng S; Si-Tu J; Hu C; Huang W; Mao Y; Qiu W; Li K; Wang D BMC Cancer; 2017 May; 17(1):360. PubMed ID: 28532481 [TBL] [Abstract][Full Text] [Related]
9. Artesunate suppresses the viability and mobility of prostate cancer cells through UCA1, the sponge of miR-184. Zhou Y; Wang X; Zhang J; He A; Wang YL; Han K; Su Y; Yin J; Lv X; Hu H Oncotarget; 2017 Mar; 8(11):18260-18270. PubMed ID: 28209917 [TBL] [Abstract][Full Text] [Related]
10. Developmentally regulated GTP-binding protein 2 levels in prostate cancer cell lines impact docetaxel-induced apoptosis. Kim SC; Lee WH; Kim SH; Abdulkhayevich AA; Park JW; Kim YM; Moon KH; Lee SH; Park S Investig Clin Urol; 2021 Jul; 62(4):485-495. PubMed ID: 34190439 [TBL] [Abstract][Full Text] [Related]
11. EGFR-mediated hyperacetylation of tubulin induced docetaxel resistance by downregulation of HDAC6 and upregulation of MCAK and PLK1 in prostate cancer cells. Pu YS; Huang CY; Wu HL; Wu JH; Su YF; Yu CR; Lu CY; Wu WJ; Huang SP; Huang YT; Hour TC Kaohsiung J Med Sci; 2024 Jan; 40(1):23-34. PubMed ID: 37916740 [TBL] [Abstract][Full Text] [Related]
12. Growth Arrest-Specific 6 (GAS6) Promotes Prostate Cancer Survival by G Lee E; Decker AM; Cackowski FC; Kana LA; Yumoto K; Jung Y; Wang J; Buttitta L; Morgan TM; Taichman RS J Cell Biochem; 2016 Dec; 117(12):2815-2824. PubMed ID: 27153245 [TBL] [Abstract][Full Text] [Related]
13. The anti-malarial drug artesunate causes cell cycle arrest and apoptosis of triple-negative MDA-MB-468 and HER2-enriched SK-BR-3 breast cancer cells. Greenshields AL; Fernando W; Hoskin DW Exp Mol Pathol; 2019 Apr; 107():10-22. PubMed ID: 30660598 [TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA MALAT1 enhances the docetaxel resistance of prostate cancer cells via miR-145-5p-mediated regulation of AKAP12. Xue D; Lu H; Xu HY; Zhou CX; He XZ J Cell Mol Med; 2018 Jun; 22(6):3223-3237. PubMed ID: 29633510 [TBL] [Abstract][Full Text] [Related]
15. Anti-Tumorigenic Potential of a Novel Orlistat-AICAR Combination in Prostate Cancer Cells. Wright C; Iyer AKV; Kaushik V; Azad N J Cell Biochem; 2017 Nov; 118(11):3834-3845. PubMed ID: 28387458 [TBL] [Abstract][Full Text] [Related]
16. The stem cell inhibitor salinomycin decreases colony formation potential and tumor-initiating population in docetaxel-sensitive and docetaxel-resistant prostate cancer cells. Gruber M; Handle F; Culig Z Prostate; 2020 Feb; 80(3):267-273. PubMed ID: 31834633 [TBL] [Abstract][Full Text] [Related]
18. Identification of lipidomic profiles associated with drug-resistant prostate cancer cells. Ingram LM; Finnerty MC; Mansoura M; Chou CW; Cummings BS Lipids Health Dis; 2021 Feb; 20(1):15. PubMed ID: 33596934 [TBL] [Abstract][Full Text] [Related]
19. Functional p53 determines docetaxel sensitivity in prostate cancer cells. Liu C; Zhu Y; Lou W; Nadiminty N; Chen X; Zhou Q; Shi XB; deVere White RW; Gao AC Prostate; 2013 Mar; 73(4):418-27. PubMed ID: 22996738 [TBL] [Abstract][Full Text] [Related]
20. Extended survivability of prostate cancer cells in the absence of trophic factors: increased proliferation, evasion of apoptosis, and the role of apoptosis proteins. Tang DG; Li L; Chopra DP; Porter AT Cancer Res; 1998 Aug; 58(15):3466-79. PubMed ID: 9699682 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]